Clinical practice guidelines have an important role to play in the promotion of quality care for individuals with traumatic brain injury (TBI). A novel series of guidelines for the treatment of patients suffering from the moderate-to-critical TBI is rolled out in the September issue of The Journal of Head Trauma Rehabilitation. It is said to be an authorized journal of the Brain Injury Association of America. The latest treatment plan incorporates insights from the medical professionals that offer patients with care from their preliminary assessment to the complete long-term follow-up process.
Bonnie Swaine, Ph.D., Université de Montréal and the Center for Interdisciplinary Rehabilitation Research (CRIR), earlier published an opening article. According to this article, the new approach will be used to confer and operate with the end users to build up a clinical practice guideline for the moderate-to-severe TBI. This approach should power the information uptake for clinicians who want to supply evidence-based care.
The latest guidelines were developed by a joint venture of researchers, policymakers, and clinicians from Ontario and Quebec. These guidelines are available in English and French language. One can access these guidelines at braininjuryguidelines.org.
On a similar note, researchers from the University of Zurich and the University Hospital Zurich earlier demonstrated that in multiple sclerosis (MS), only particular type of T cells are not responsible for causing an inflammation and injury in the brain. But, B cells, unusual types of immune cells, also play a key role in the same. These B cells are responsible for activating T cells in the blood. The latest invention is supposed to clarify how the novel MS medicines take effect, opening up new options for treating this disease.
MS is a critical autoimmune disease of the central nervous system. In this disease, individual’s own immune cells are attacking and damaging the layer surrounding the nerve cells in the brain and spinal cord. This attack is responsible for affecting the capability of these immune cells to communicate with each other.